Capital Research Global Investors Conmed Corp Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Conmed Corp stock. As of the latest transaction made, Capital Research Global Investors holds 1,544,542 shares of CNMD stock, worth $106 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,544,542
Previous 1,709,441
9.65%
Holding current value
$106 Million
Previous $118 Million
6.26%
% of portfolio
0.02%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding CNMD
# of Institutions
305Shares Held
33.1MCall Options Held
123KPut Options Held
24.2K-
Black Rock Inc. New York, NY4.99MShares$344 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$243 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.78MShares$192 Million0.91% of portfolio
-
Bank Of America Corp Charlotte, NC1.37MShares$94.3 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$94.1 Million0.62% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.1B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...